1. Academic Validation
  2. The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway

The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway

  • Front Med (Lausanne). 2023 Jun 16:10:1164656. doi: 10.3389/fmed.2023.1164656.
Nan Zhang # 1 Huaxing Shen # 1 Baobao Chen 1 Honggang Hu 1 Chao Liu 1 Yan Chen 2 Wei Cong 1
Affiliations

Affiliations

  • 1 School of Medicine or Institute of Translational Medicine, Shanghai University, Shanghai, China.
  • 2 Department of Pharmacy, Medical Supplies Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
  • # Contributed equally.
Abstract

Wnt signaling plays an important role in many biological processes such as stem cell self-renewal, cell proliferation, migration, and differentiation. The β-catenin-dependent signaling pathway mainly regulates cell proliferation, differentiation, and migration. In the Wnt/β-catenin signaling pathway, the Wnt family ligands transduce signals through LRP5/6 and Frizzled receptors to the Wnt/β-catenin signaling cascades. Wnt-targeted therapy has garnered extensive attention. The most commonly used approach in targeted therapy is small-molecule regulators. However, it is difficult for small-molecule regulators to make great progress due to their inherent defects. Therapeutic peptide regulators targeting the Wnt signaling pathway have become an alternative therapy, promising to fill the gaps in the clinical application of small-molecule regulators. In this review, we describe recent advances in peptide regulators for Wnt/β-catenin signaling.

Keywords

Wnt/β-catenin signaling pathway; biologics; peptide regulators; peptide regulators for Wnt/β-catenin; recent progress; small molecular drugs.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》